newsfilter
← Latest News
GlobeNewswire·

Instil Bio Reports First Quarter 2022 Financial Results and Provides Corporate Update

Targeting completion of enrollment in registrational cohort of DELTA-1 in 2022 Presenting preclinical efficacy and safety data of CoStAR platform at ASCO 2022 Cash runway into 2024 through key clinical data expected in 2023 DALLAS, May 16, 2022